These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3233627)

  • 21. [A study of cefoperazone prostatic tissue levels: difference between the gland and capsule].
    Fukushima S; Miura T; Kondo I; Fujii H; Hirokawa M; Iwasaki A; Ishizuka E; Kitajima N
    Hinyokika Kiyo; 1983 Jan; 29(1):87-93. PubMed ID: 6203376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
    Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG;
    Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis.
    Bielecka-Grzela S; Klimowicz A
    Pol J Pharmacol; 2003; 55(4):613-8. PubMed ID: 14581720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study].
    Valdevenito Sepúlveda JP
    Arch Esp Urol; 2004; 57(1):48-57. PubMed ID: 15112871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis.
    Tsaganos T; Kouki P; Digenis P; Giamarellou H; Giamarellos-Bourboulis EJ; Kanellakopoulou K
    Int J Antimicrob Agents; 2008 Jul; 32(1):46-9. PubMed ID: 18534825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tissue concentrations of mezlocillin in prostate adenomas following intravenous bolus injections and continuous infusions].
    Naber K; Adam D
    Fortschr Med; 1983 Nov; 101(41):1862-8. PubMed ID: 6197351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver tissue concentrations of levofloxacin after single intravenous administration of 500 mg for antibiotic prophylaxis in liver surgery.
    Weinrich M; Scheingraber S; Stremovskaia T; Schilling MK; Kees F; Pistorius GA
    Int J Antimicrob Agents; 2006 Sep; 28(3):221-5. PubMed ID: 16904875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefotaxime in transurethral prostatectomy.
    Fujita K; Murayama T
    Clin Ther; 1988; 10 Spec No():43-6. PubMed ID: 3233629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prostatic tissue and fluid levels of DL-8280].
    Kumon H; Furukawa M; Mizuno A; Miyata K; Akazawa N; Ohmori H; Katayama Y; Akaeda T
    Hinyokika Kiyo; 1984 Sep; 30(9):1297-305. PubMed ID: 6596879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
    Nawishy S; Moukhtar I; Sabbour M
    Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Norfloxacin concentration in human prostatic tissue after 3 days administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jul; 35(7):1261-5. PubMed ID: 2478009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostatic tissue concentrations and serum levels of Myocamicin in human subjects.
    Fraschini F; Scaglione F; Cicchetti F; Rossi M; Borghi C; Alfano G; Maierna G; Balsamo V; Gattei G
    Drugs Exp Clin Res; 1988; 14(4):253-5. PubMed ID: 3262495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral ofloxacin versus intramuscular ceftriaxone in antibiotic prophylaxis in transurethral prostate resection].
    Botto H; Butreau-Lemaire M; Levy S; Delval C
    Prog Urol; 1993; 3(4):569-75. PubMed ID: 8401617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an antimicrobial agent to prevent complications following transurethral resection of the prostate. Furadantin.
    Gross M
    Int Surg; 1969 Jun; 51(6):475-8. PubMed ID: 4182528
    [No Abstract]   [Full Text] [Related]  

  • 37. Transurethral laser therapy and urinary tract infections.
    Miller J; Ludwig M; Schroeder-Printzen I; Schiefer HG; Weidner W
    Ann Urol (Paris); 1996; 30(3):131-8. PubMed ID: 8766150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of serum ofloxacin concentration and serum creatinine level in patients on prolonged therapy.
    Yew WW; Wong CF; Wong PC; Cheung SW; Chan CY; Cheng AF
    Int J Clin Pharmacol Res; 1993; 13(5):243-5. PubMed ID: 8200719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections.
    Kuck EM; Bouter KP; Hoekstra JB; Conemans JM; Diepersloot RJ
    Foot Ankle Int; 1998 Jan; 19(1):38-40. PubMed ID: 9462911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy after prostatectomy--effects of long term administration of Pivmecillinam (PMPC)].
    Sagawa S; Takaha M; Sonoda T; Shin T; Yano H; Mizutani S; Sakurai T; Kotake T; Nakamura T; Nagano S
    Hinyokika Kiyo; 1984 Mar; 30(3):423-30. PubMed ID: 6205570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.